Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
477
mentions
- News 250
- X 125
- Facebook 58
- Blogs 30
- +2 more
Robert P Giugliano
PubHawk tracks social media discussions for 11 articles by authors named Robert P Giugliano.
Mentions
1,481
Peak: 87 in Dec 2024
across 11 tracked articles
Extended reach
10,426,566
potential audience
Total likes
85,632
Video views
3,831,516
Mentions per month
Jun 2015 – Dec 2025Where it's discussed
-
X / Twitter736 posts
-
News493 articles
-
Facebook159 posts
-
Blogs50 articles
-
YouTube34 videos
-
Reddit6 posts
-
Bluesky3 posts
Tracked by PubHawk
Most discussed articles
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
210
mentions
- News 119
- X 87
- YouTube 2
- Facebook 2
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
210
mentions
- X 87
- Facebook 59
- News 53
- Blogs 9
- +1 more
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab.
131
mentions
- X 122
- News 3
- Bluesky 2
- YouTube 2
- +1 more
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
130
mentions
- X 117
- News 6
- YouTube 3
- Reddit 2
- +1 more
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association.
125
mentions
- X 110
- News 12
- YouTube 2
- Bluesky 1
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy.
59
mentions
- X 52
- News 3
- YouTube 2
- Facebook 2
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
58
mentions
- Facebook 21
- News 20
- X 9
- YouTube 4
- +1 more
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
43
mentions
- News 22
- X 8
- Facebook 5
- Blogs 5
- +1 more
Inflammatory and Cholesterol Risk in the FOURIER Trial.
28
mentions
- X 17
- Facebook 6
- News 3
- YouTube 2
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
10
mentions
- Facebook 4
- X 2
- YouTube 2
- News 2
From PubMed
All publications
Searching PubMed…